TG Therapeutics | Attività Correnti



Current Assets Cambiamento Data
AbbVie USD 25.58B 2.2B 2024-12
Alaunos Therapeutics USD 3.55M 1.13M 2024-09
Amgen USD 29.03B 2.26B 2024-12
Ardelyx USD 356.45M 72.35M 2024-12
Arrowhead Research USD 570.54M 124.93M 2024-12
Bayer EUR 34.44B 1.31B 2024-12
Biogen USD 7.46B 626.3M 2024-12
Corcept Therapeutics USD 471.6M 4.62M 2024-12
Dynavax Technologies USD 848.94M 77.3M 2024-12
Gilead Sciences USD 19.17B 4.39B 2024-12
J&J USD 55.89B 2.64B 2024-12
Novartis USD 29.7B 1.56B 2024-12
PTC Therapeutics USD 1.37B 83.98M 2024-12
Regeneron Pharmaceuticals USD 27.21B 7.88B 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
TG Therapeutics USD 566.36M 7.71M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



TG Therapeutics Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.